Vasa Vasorum in Atherosclerosis and Clinical Significance

Abstract

Atherosclerosis is a chronic inflammatory disease that leads to several acute cardiovascular complications with poor prognosis. For decades, the role of the adventitial vasa vasorum (VV) in the initiation and progression of atherosclerosis has received broad attention. The presence of VV neovascularization precedes the apparent symptoms of clinical atherosclerosis. VV also mediates inflammatory cell infiltration, intimal thickening, intraplaque hemorrhage, and subsequent atherothrombosis that results in stroke or myocardial infarction. Intraplaque neovessels originating from VV can be immature and hence susceptible to leakage, and are thus regarded as the leading cause of intraplaque hemorrhage. Evidence supports VV as a new surrogate target of atherosclerosis evaluation and treatment. This review provides an overview into the relationship between VV and atherosclerosis, including the anatomy and function of VV, the stimuli of VV neovascularization, and the available underlying mechanisms that lead to poor prognosis. We also summarize translational researches on VV imaging modalities and potential therapies that target VV neovascularization or its stimuli.

Local Thickness of Epicardial Adipose Tissue Surrounding the Left Anterior Descending Artery Is a Simple Predictor of Coronary Artery Disease ― New Prediction Model in Combination With Framingham Risk Score ―

“…[25][26][27] In contrast, the progression of atherosclerotic plaque 28 and the presence of an oxygeninsufficient microenvironment, the inner layers may provide an inside-to-outside signal, similar to hypoxic conditions, resulting in EAT accumulation. 29 This may be supported by our previous observation that pro-inflammatory cytokine profiles are more prominently enhanced in locations where severe atherosclerosis is observed. 1,30…”

Arteriosclerotic Changes after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Drugs in Patients with Exudative Age-Related Macular Degeneration

“…The vasa vasorum has been thought to be not only a function of intimal thickness but also involved in atherosclerotic progression [26]. In animal models, an increased vasa vasorum was associated with intimal thickening and endothelial dysfunction, and these effects were blocked with angiogenic inhibitors [27,28].…”

Fibroblast growth factor‐2/platelet‐derived growth factor enhances atherosclerotic plaque stability

“…Studies of the initiation phase using a rabbit model fed an atherogenic diet for 3 weeks showed that local delivery of bevacizumab (a monoclonal antibody against VEGF‐A) inhibited plaque angiogenesis, resulting in smaller atherosclerotic plaques . Despite their clinical relevance, there are few studies of anti‐angiogenic therapy on the progression and complication stages and inappropriate anti‐angiogenic therapy at these two stages can potentially cause hypoxia and induce endothelial apoptosis, resulting in the loss of integrity of the endothelial vessel lining (bleeding) . This observation raised concerns regarding the importance of vascular‐normalization therapy in atherosclerotic plaque .…”